Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN) -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (765)	3/26/2007 10:01:08 PM
From: IRWIN JAMES FRANKEL	Respond to of 824

>>How does this work in practice - it negates the whole co-pay and could encourage drug company to set price at many times what it should since it more than makes up the co-pay in extra insurance proceeds. Deductibles and co-pays are there for a reason. Not really sure. Maybe someone else KNOWS. But I suspect that ALXN having a separate foundation to help people with their copays is just ALXN emulating practices of other drug companies. As you suggest - this should not work. But I suspect it does. ij